Deep-Learning Model Based on Chest X-Ray Helps Predict MACE
By Elana Gotkine HealthDay Reporter
TUESDAY, March 26, 2024 -- A deep-learning model based on a chest radiograph (CXR) for cardiovascular disease (CVD) risk (CXR CVD-Risk) predicts major adverse cardiovascular events (MACE) beyond the clinical standard, according to a study published online March 26 in the Annals of Internal Medicine.
Jakob Weiss, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues developed and tested CXR CVD-Risk, which estimates 10-year risk for MACE from routine CXR, and compared the performance to that of the traditional atherosclerotic CVD (ASCVD) risk score. The CXR CVD-Risk model was developed using data from a cancer screening trial and was externally validated in 8,869 outpatients with unknown ASCVD risk and 2,132 outpatients with known ASCVD risk.
The researchers found that after adjustment for risk factors, the 10-year risk for MACE was higher for those with a risk of 7.5 percent or higher as predicted by CXR CVD-Risk among 8,869 outpatients with unknown ASCVD risk (adjusted hazard ratio, 1.73). CXR CVD-Risk predicted MACE beyond the traditional ASCVD risk score in the additional 2,132 outpatients with known ASCVD risk (adjusted hazard ratio, 1.88).
"Opportunistic screening of CXRs may help identify individuals at high risk for cardiovascular disease, prompting risk factor assessment and targeted prevention," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019
THURSDAY, June 27, 2024 -- The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June...
hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis
THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.